A new study suggests that the flu vaccine produced by the makers of the blockbuster Stinger mouthwashes and the magic mouthwash in the movie Magic is a risky medicine.
The study published Monday in the journal JAMA Internal Medicine found that flu shots produced by Merck and GlaxoSmithKline contain fluoride and are linked to an increased risk of serious side effects.
Flu vaccines are the most widely used vaccine in the U.S. The Centers for Disease Control and Prevention recommends the flu shot as the most effective way to prevent flu.
The agency recommends it be given to people at least three months after exposure.
The new study found the flu shots had elevated levels of fluoride.
Fluoride is naturally occurring and is part of the fluoride compound that is used in the body to make bones and teeth.
Studies have shown that the concentration of fluoride in the saliva of people who are older, sicker or have chronic illnesses are higher than in people who aren’t.
Merck spokeswoman Laura Dussault said that while the safety of the flu vaccines is still being investigated, “we take the safety and effectiveness of all vaccines very seriously and we look forward to sharing our results with the FDA as soon as possible.”
Merck also released a statement that said: “The safety and efficacy of the Stinger, GlaxosmithKline, and Merck vaccines are in our own laboratories, and we take these issues seriously.
We have taken additional steps to ensure that our vaccines are safe and effective.”
Merks CEO Robert Stapleton said that Glaxoblastix and Stinger are “not as effective” as the flu jab and said the vaccine is still a safer option.
Stapley said that Stinger and Merks are working together to develop a new formulation of the vaccine.
He also said that Merck will “continue to make every effort to get this vaccine out into the community as quickly as possible so that all Americans can receive it.”
Merk has already announced it is changing its manufacturing processes to reduce risks of exposure to fluoride and has also pledged to stop using the vaccine in its products.
Merk said it is working to make the flu-shot more affordable.
The company has also said it will stop using its flu vaccine in clinical trials for the next several years.
In response to the new study, Merck issued a statement saying that “the safety and safety profile of this vaccine is not at issue in the study, which was conducted by a third-party and was not designed or approved by Merkels safety team.
Merkells safety team is working closely with the CDC and FDA to develop appropriate guidance to ensure the safety profile is not impacted by the flu strain.”
The company also said in a statement: “We continue to work with the Centers for Diseases Control and Disease Control to continue to identify, prevent, and control the spread of the pandemic.
As a result of this work, we will stop production of Stinger flu vaccine products and all flu vaccines.”
The Centers For Disease Control said that it will be looking into the new safety study.
“Flu vaccine safety is a critical issue for us as we develop and implement a comprehensive response strategy to prevent and control a pandemic,” said CDC Director Tom Frieden.
“This study confirms what we have been saying all along: Flu vaccines need to be produced in a way that protects our citizens, our families, and our environment.”
Staplette, who was a Merck vaccine safety expert when he was Merck’s president, told ABC News that Merkel “has a strong record of doing this work and that’s why they’re so committed to it.”
He said Merck has always been committed to “putting people first.”
Merkel has also been criticized for selling flu vaccines in China.
China has the world’s largest flu outbreak.
The flu strain that causes the pandemics that kills more than 7,000 people every year is not known there.
The virus has been found in the lungs of people infected with the SARS virus.
The SARS strain, which killed more than 11,000, is not believed to be a flu variant.
But China is a major supplier of flu vaccines to the U, where they are sold at a much lower price.
A vaccine produced in China for use in the United States cost $4.99, and it can cost as little as $7.50.
Stipulations in the flu vaccination plan have also raised concerns.
Last year, the Food and Drug Administration approved an experimental drug called Avanzax to treat the coronavirus.
The drug is a derivative of a drug called fipronil.
The FDA is reviewing the drug’s safety record and is expected to approve it this month.
The Drug Enforcement Administration is also reviewing the drugs safety record.
The drugs manufacturer is Merck, not Pfizer,